TrialThe Lancet. Global health2025

Effectiveness and acceptability of a 24-h interval versus a 48-h interval between mifepristone intake and misoprostol administration for in-hospital abortion at 9-20 gestational weeks: an international, open-label, randomised, controlled, non-inferiority trial.

Margit Endler et al.PubMed ↗Publisher ↗

No numbers read from the abstract.